June 29, 2022
Certain problems related to health-related quality of life (HRQOL) became more common among patients with atopic dermatitis since the start of the COVID-19 pandemic.
June 21, 2022
Recent meta-analysis takes a look at possible adverse effects of the acne medicine, their frequency and severity.
June 15, 2022
New options are being developed for conditions including psoriatic arthritis, ulcerative colitis, and asthma.
June 14, 2022
The drug has previously been approved to treat moderately to severely active rheumatoid arthritis.
The pipeline includes next-in-class treatments for melanoma, NSCLC, breast cancer, and multiple myeloma.
June 10, 2022
Education, honesty, and communication skills are key when it comes to creating treatment regimens.
June 09, 2022
Sanofi and Regeneron Pharmaceuticals, Inc announced the FDA approval of dupilumab. It is now the first biologic medicine for children from 6 months to 5 years old with moderate to severe atopic dermatitis.
June 08, 2022
Recent research puts the role of sunscreens in a whole new light, including need-to-know information on SPF, how to improve adherence and address patient concerns about sunscreen safety, and more.
May 25, 2022
Data gathered from an electronic medical record found the results in a real-world patient population with atopic dermatitis were consistent with those found in clinical trials.
May 23, 2022
Matthew Zirwas, MD, shares his step-by-step pearls for quelling the pruritic skin condition.
